Takeda takes another step into India with Advinus R&D alliance
This article was originally published in Scrip
There has long been speculation that Takeda may be in line for a commercial acquisition in India, but for the time being at least Asia's largest pharma firm has opted for the collaborative R&D approach.
You may also be interested in...
Takeda’s alliance with Advinus Therapeutics, a much-touted deal that had put the spotlight on the Indian R&D services firm, has ended. Advinus is currently in the process of divesting of its contract research business to Eurofins Scientific.
Eurofins Scientific has snapped up the contract research business of Advinus Therapeutics, continuing its ongoing acquisition momentum. The deal also ends long-running speculation around a potential sale of Advinus, amid its rocky recent run.
A new report focused on the European market says that winning trust is the key to taking AI adoption to the next stage. That approach was praised by MedTech Europe CEO Serge Bernasconi.